DNA repair of myeloma plasma cells correlates with clinical outcome: The effect of the nonhomologous end-joining inhibitor SCR7

MLA

Gkotzamanidou, M.Terpos, E.Bamia, C.Munshi, N. C.Dimopoulos, M. A.Souliotis, V. L. DNA Repair of Myeloma Plasma Cells Correlates with Clinical Outcome: The Effect of the Nonhomologous End-Joining Inhibitor SCR7. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1478880833&authtype=sso&custid=ns315887.

APA

Gkotzamanidou, M. T. E. B. C. M. N. C. D. M. A. S. V. L. (2016). DNA repair of myeloma plasma cells correlates with clinical outcome: The effect of the nonhomologous end-joining inhibitor SCR7.

Chicago

Gkotzamanidou, M. Terpos, E. Bamia, C. Munshi, N.C. Dimopoulos, M.A. Souliotis, V.L. 2016. “DNA Repair of Myeloma Plasma Cells Correlates with Clinical Outcome: The Effect of the Nonhomologous End-Joining Inhibitor SCR7.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1478880833&authtype=sso&custid=ns315887.